Annual EPS
-$2311.76
-$4867.72-190.45%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual earnings per share is -$2311.76, with the most recent change of -$4867.72 (-190.45%) on December 31, 2023.
- During the last 3 years, APVO annual EPS has risen by +$6202.68 (+72.85%).
- APVO annual EPS is now -131.40% below its all-time high of $7363.25, reached on December 31, 2017.
Performance
APVO EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$17.76
+$2701.00+99.35%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly earnings per share is -$17.76, with the most recent change of +$2701.00 (+99.35%) on September 30, 2024.
- Over the past year, APVO quarterly EPS has increased by +$475.88 (+96.40%).
- APVO quarterly EPS is now -100.04% below its all-time high of $40.28 thousand, reached on September 30, 2017.
Performance
APVO Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$3598.31
+$802.16+18.23%
September 30, 2024
Summary
- As of February 8, 2025, APVO TTM earnings per share is -$3598.31, with the most recent change of +$802.16 (+18.23%) on September 30, 2024.
- Over the past year, APVO TTM EPS has dropped by -$931.66 (-34.94%).
- APVO TTM EPS is now -149.18% below its all-time high of $7316.09, reached on December 31, 2017.
Performance
APVO TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
APVO EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -190.4% | +96.4% | -34.9% |
| 3 y3 years | +72.8% | +96.4% | -34.9% |
| 5 y5 years | +95.8% | +99.5% | +86.5% |
APVO EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -190.4% | +76.6% | -100.2% | +99.3% | -162.7% | +63.7% |
| 5 y | 5-year | -190.4% | +89.8% | -100.2% | +99.5% | -162.7% | +86.5% |
| alltime | all time | -131.4% | +98.2% | -100.0% | +100.0% | -149.2% | +97.0% |
Aptevo Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.76(-99.3%) | -$3598.31(-18.2%) |
| Jun 2024 | - | -$2718.76(+638.5%) | -$4400.47(+19.6%) |
| Mar 2024 | - | -$368.15(-25.4%) | -$3677.86(+37.9%) |
| Dec 2023 | -$2311.76(-190.4%) | -$493.64(-39.8%) | -$2666.65(-28.3%) |
| Sep 2023 | - | -$819.92(-58.9%) | -$3719.61(-30.4%) |
| Jun 2023 | - | -$1996.15(-410.4%) | -$5341.69(-193.1%) |
| Mar 2023 | - | $643.06(-141.6%) | $5738.70(+123.1%) |
| Dec 2022 | $2555.96(-125.9%) | -$1546.60(-36.7%) | $2572.24(+25.4%) |
| Sep 2022 | - | -$2442.00(-126.9%) | $2051.28(-5.3%) |
| Jun 2022 | - | $9084.24(-460.0%) | $2165.24(-122.2%) |
| Mar 2022 | - | -$2523.40(+22.0%) | -$9768.00(-1.5%) |
| Dec 2021 | -$9881.96(+16.1%) | -$2067.56(-11.2%) | -$9914.52(-9.6%) |
| Sep 2021 | - | -$2328.04(-18.3%) | -$10.97 K(-9.0%) |
| Jun 2021 | - | -$2849.00(+6.7%) | -$12.06 K(-4.5%) |
| Mar 2021 | - | -$2669.92(-14.6%) | -$12.63 K(+48.4%) |
| Dec 2020 | -$8514.44(-62.3%) | -$3125.76(-8.6%) | -$8514.44(-8.1%) |
| Sep 2020 | - | -$3418.80(0.0%) | -$9263.32(-0.9%) |
| Jun 2020 | - | -$3418.80(-336.0%) | -$9344.72(-26.2%) |
| Mar 2020 | - | $1448.92(-137.4%) | -$12.67 K(-52.3%) |
| Dec 2019 | -$22.56 K | -$3874.64(+10.7%) | -$26.55 K(-27.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$3500.20(-48.1%) | -$36.81 K(-19.9%) |
| Jun 2019 | - | -$6739.92(-45.8%) | -$45.94 K(-12.4%) |
| Mar 2019 | - | -$12.44 K(-12.0%) | -$52.43 K(-3.0%) |
| Dec 2018 | -$54.47 K(-839.8%) | -$14.13 K(+11.8%) | -$54.07 K(+7.6%) |
| Sep 2018 | - | -$12.64 K(-4.4%) | -$50.25 K(-1978.2%) |
| Jun 2018 | - | -$13.22 K(-6.1%) | $2675.20(-31.7%) |
| Mar 2018 | - | -$14.08 K(+36.6%) | $3918.89(-46.4%) |
| Dec 2017 | $7363.25(-105.8%) | -$10.31 K(-125.6%) | $7316.09(+803.0%) |
| Sep 2017 | - | $40.28 K(-436.3%) | $810.17(-100.7%) |
| Jun 2017 | - | -$11.98 K(+12.1%) | -$120.26 K(+11.1%) |
| Mar 2017 | - | -$10.68 K(-36.5%) | -$108.28 K(+10.9%) |
| Dec 2016 | -$126.45 K(>+9900.0%) | -$16.81 K(-79.2%) | -$97.60 K(+20.8%) |
| Sep 2016 | - | -$80.79 K(>+9900.0%) | -$80.79 K(>+9900.0%) |
| Jun 2016 | - | -$0.64(-0.4%) | -$2.79(-8.0%) |
| Mar 2016 | - | -$0.64(-28.0%) | -$3.03(+3.1%) |
| Dec 2015 | -$2.93(+16.0%) | -$0.89(+41.1%) | -$2.93(+43.2%) |
| Sep 2015 | - | -$0.63(-28.4%) | -$2.05(+44.1%) |
| Jun 2015 | - | -$0.88(+60.7%) | -$1.42(+160.7%) |
| Mar 2015 | - | -$0.55 | -$0.55 |
| Dec 2014 | -$2.53(-4.2%) | - | - |
| Dec 2013 | -$2.64 | - | - |
FAQ
- What is Aptevo Therapeutics annual earnings per share?
- What is the all time high annual EPS for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual EPS year-on-year change?
- What is Aptevo Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly EPS year-on-year change?
- What is Aptevo Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Aptevo Therapeutics?
- What is Aptevo Therapeutics TTM EPS year-on-year change?
What is Aptevo Therapeutics annual earnings per share?
The current annual EPS of APVO is -$2311.76
What is the all time high annual EPS for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual earnings per share is $7363.25
What is Aptevo Therapeutics annual EPS year-on-year change?
Over the past year, APVO annual earnings per share has changed by -$4867.72 (-190.45%)
What is Aptevo Therapeutics quarterly earnings per share?
The current quarterly EPS of APVO is -$17.76
What is the all time high quarterly EPS for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly earnings per share is $40.28 K
What is Aptevo Therapeutics quarterly EPS year-on-year change?
Over the past year, APVO quarterly earnings per share has changed by +$475.88 (+96.40%)
What is Aptevo Therapeutics TTM earnings per share?
The current TTM EPS of APVO is -$3598.31
What is the all time high TTM EPS for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM earnings per share is $7316.09
What is Aptevo Therapeutics TTM EPS year-on-year change?
Over the past year, APVO TTM earnings per share has changed by -$931.66 (-34.94%)